Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial - Balanescu, A R; Citera, G; Pascual-Ramos, V (Ann Rheum Dis, 2022)